HETERODIMERIC BISPECIFIC ANTIBODIES
    1.
    发明申请
    HETERODIMERIC BISPECIFIC ANTIBODIES 审中-公开
    双相异种抗体

    公开(公告)号:US20140308285A1

    公开(公告)日:2014-10-16

    申请号:US14207368

    申请日:2014-03-12

    Applicant: Amgen Inc.

    Abstract: Provided herein are heterodimeric bispecific antibodies that can mediate cytolysis of a target cell by an immune effector cell, nucleic acids encoding such antibodies, methods of making such antibodies, and methods of using such antibodies. These antibodies comprise two different polypeptide chains, each comprising two immunoglobulin variable regions and, optionally, a half life-extending moiety.

    Abstract translation: 本文提供了可以通过免疫效应细胞介导靶细胞的细胞溶解的异二聚体双特异性抗体,编码这种抗体的核酸,制备此类抗体的方法以及使用这种抗体的方法。 这些抗体包含两个不同的多肽链,每条链包含两个免疫球蛋白可变区和任选的半衰期延长部分。

    BISPECIFIC-Fc MOLECULES
    2.
    发明申请
    BISPECIFIC-Fc MOLECULES 审中-公开
    BISPECIFIC-Fc分子

    公开(公告)号:US20140302037A1

    公开(公告)日:2014-10-09

    申请号:US14210178

    申请日:2014-03-13

    Applicant: Amgen Inc.

    Abstract: Described herein is a bispecific molecule containing an Fc polypeptide chain and immunoglobulin variable regions. Also provided are pharmaceutical formulations comprising such molecules, nucleic acids encoding such molecules, host cells containing such nucleic acids, methods of making such molecules, and methods of using such molecules.

    Abstract translation: 本文描述的是含有Fc多肽链和免疫球蛋白可变区的双特异性分子。 还提供了包含这种分子的药物制剂,编码这种分子的核酸,含有这种核酸的宿主细胞,制备这种分子的方法,以及使用这种分子的方法。

Patent Agency Ranking